Research and Markets: 2015 Clinical Chemistry and Immunodiagnostics: A Market in Transition Amid Regulatory Uncertainty and Intensifying Competition

Research and Markets (http://www.researchandmarkets.com/research/v27n86/2015_clinical) has announced the addition of the "2015 Clinical Chemistry and Immunodiagnostics: A Market in Transition Amid Regulatory Uncertainty and Intensifying Competition -Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence" report to their offering.

The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.

Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.

Scope of the Report:

Geographic Coverage:

• France
• Germany
• Italy
• Japan
• Spain
• UK
• USA
  

Worldwide Market Overview:

• Estimates of facilities performing clinical chemistry and immunodiagnostic tests by country.
• Test volume and sales projections by country.
  

Strategic Recommendations:

• New product development opportunities with significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
  

Current and Emerging Products:

• Analysis of current and emerging clinical chemistry and immunodiagnostic tests.
• Review of current instrumentation technologies, and feature comparison of high, medium and low-volume/POC analyzers.
  

Technology Review:

• Assessment of current and emerging technologies, and their potential market applications.
• Comprehensive lists of companies developing or marketing new technologies and products by test.
  

Strategic assessments of major suppliers and emerging market entrants, including their:

• Sales
• Product
  
• Portfolios
• Marketing tactics
• Collaborative arrangements
  
• New products in R&D.
  

Companies mentioned:

• Abbott Laboratories
• AdnaGen
• Agilent Technologies
• Beckman Coulter/Danaher
• Biomedical Diagnostics
• BioMerieux
• Bio-Rad
• DiaSorin
• Eiken
• Fujirebio
• Grifols
• Instrumentation Laboratory
• Kyowa Medex
• Matritech/Alere
• Ortho-Clinical Diagnostics
• Quest Diagnostics
• Roche
• Siemens
• Sysmex
• Thermo Fisher
• Tosoh
• Wako
• Wallac/PE
  

For more information visit http://www.researchandmarkets.com/research/v27n86/2015_clinical

View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005191/en/